Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. for CNY 160 million on December 15, 2022.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.34 CNY | -8.02% | +1.38% | -33.81% |
1st Jan change | Capi. | |
---|---|---|
-33.81% | 209M | |
-3.54% | 9.39B | |
+2.16% | 1.45B | |
-2.08% | 1.43B | |
-5.80% | 1.21B | |
-16.56% | 899M | |
+2.34% | 480M | |
+2.71% | 440M | |
-47.72% | 369M | |
-21.86% | 356M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 160 million.